Search for: "Matrix Laboratories, Inc." Results 1 - 13 of 13
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2010, 9:59 pm by Patent Docs
Matrix Laboratories, Ltd., decided last Thursday, the Federal Circuit affirmed a determination by the District Court for the District of New Jersey that Matrix Laboratories, Ltd., Mylan Inc., Mylan Laboratories, Inc., and Mylan Pharmaceuticals, Inc. [read post]
2 Apr 2015, 9:59 pm by Patent Docs
(or Matrix Laboratories, which is now Mylan) was unable to invalidate one of the Orange Book... [read post]
25 Mar 2012, 9:25 pm by Patent Docs
Mylan Laboratories Ltd. et al. 1:12-cv-00300; filed March 12, 2012 in the District Court of Delaware • Plaintiffs: AstraZeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. • Defendants: Mylan Laboratories Ltd.; Mylan Laboratories Inc.; Mylan Inc.; Matrix Laboratories Ltd.; Matrix Laboratories Inc. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Mylan Pharmaceuticals Inc., Mylan, Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
26 Jan 2011, 11:27 am by Eric Schweibenz
The complaint names Sharp Electronics Corporation of Mahwah, New Jersey and Sharp Laboratories of America, Inc. of Camas, Washington as wholly-owned subsidiaries that conduct significant research and development, manufacturing, and technical support activities in the U.S. [read post]
21 Nov 2016, 12:00 am
  The Court of Appeal reiterated the approach to construction of numerical features and ranges in patent claims as set out in paragraph 38 of Smith & Nephew plc v ConvaTec Technologies Inc [2015] EWCA Civ 607. [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Filed August 2, 2010 by Dolby Laboratories, Inc. (3)  95/000,563 (paper filed) – U.S. [read post]
11 Jan 2011, 6:08 pm
Researchers concluded that a properly-administered HGN test would correctly identify a suspect as having a BAC at or above 0.10 percent seventy-seven percent of the time, and that when the HGN and walk-and-turn results were combined using a decision matrix, the two tests would correctly identify a suspect as having a BAC at or greater than 0.10 percent eighty percent of the time. [read post]
15 Dec 2019, 9:01 pm by News Desk
FDA laboratory analyses of the environmental swabs found the presence of Listeria monocytogenes, a human pathogen, in your facility, which matches the same strain found during FDA’s 2017 inspection,” according to the warning letter. [read post]
21 Feb 2019, 4:00 am by Administrator
Periodically on Thursdays, we present a significant excerpt, usually from a recently published book or journal article. [read post]